Patents by Inventor Masaki Miyazaki

Masaki Miyazaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11943398
    Abstract: A maintenance support system includes a network interface, a memory, and a processor configured to, upon receipt of first information indicating a status of a first apparatus via the network interface, store the first information in the memory, upon receipt of second information indicating a status of a second apparatus via the network interface, store the second information in the memory, and determine a priority of on-site maintenance between the first and second apparatuses based on the first and second information stored in the memory.
    Type: Grant
    Filed: April 27, 2023
    Date of Patent: March 26, 2024
    Assignee: Toshiba Tec Kabushiki Kaisha
    Inventors: Sou Miyazaki, Hiroyo Tanaka, Kazuhiro Ogura, Masaki Narahashi, Satoshi Oyama
  • Patent number: 11943414
    Abstract: An image processing apparatus includes a display device and a processor. The processor is configured to generate a first screen for display on the display device and on which one of a plurality of malfunctioning part candidates of the image processing apparatus and one of a plurality of timings at which a particular sound was output by the image processing apparatus that malfunctioned, are selectable, when a first malfunctioning part candidate and a first timing are selected on the first screen, generate a second screen for display on the display device and on which one or more reference sounds corresponding to the particular sound are selectable, and when one of the reference sounds is selected on the second screen, generate error information indicating the first malfunctioning part candidate and the selected reference sound.
    Type: Grant
    Filed: April 13, 2023
    Date of Patent: March 26, 2024
    Assignee: Toshiba Tec Kabushiki Kaisha
    Inventors: Sou Miyazaki, Hiroyo Tanaka, Kazuhiro Ogura, Masaki Narahashi, Satoshi Oyama, Tatsuya Inagi
  • Publication number: 20220106324
    Abstract: A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.
    Type: Application
    Filed: April 19, 2021
    Publication date: April 7, 2022
    Inventors: Yuuichi SUGIMOTO, Kouichi UOTO, Takanori WAKABAYASHI, Masaki MIYAZAKI, Masaki SETOGUCHI, Toru TANIGUCHI, Keisuke YOSHIDA, Akitake YAMAGUCHI, Shoko YOSHIDA
  • Publication number: 20140121196
    Abstract: A compound that inhibits interaction between, murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.
    Type: Application
    Filed: November 14, 2013
    Publication date: May 1, 2014
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Yuuichi Sugimoto, Kouichi Uoto, Takanori Wakabayashi, Masaki Miyazaki, Masaki Setoguchi, Toru Taniguchi, Keisuke Yoshida, Akitake Yamaguchi, Shoko Yoshida
  • Patent number: 8629133
    Abstract: A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: January 14, 2014
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Yuuichi Sugimoto, Kouichi Uoto, Takanori Wakabayashi, Masaki Miyazaki, Masaki Setoguchi, Toru Taniguchi, Keisuke Yoshida, Akitake Yamaguchi, Shoko Yoshida
  • Publication number: 20130165424
    Abstract: A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.
    Type: Application
    Filed: March 9, 2012
    Publication date: June 27, 2013
    Inventors: Yuuichi Sugimoto, Kouichi Uoto, Takanori Wakabayashi, Masaki Miyazaki, Masaki Setoguchi, Toru Taniguchi, Keisuke Yoshida, Akitake Yamaguchi, Shoko Yoshida
  • Patent number: 8404691
    Abstract: There is provided compounds that inhibit interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. Compounds include imidazothiazole derivatives that can inhibit interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity.
    Type: Grant
    Filed: July 15, 2011
    Date of Patent: March 26, 2013
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Kouichi Uoto, Yuuichi Sugimoto, Hiroyuki Naito, Masaki Miyazaki, Keisuke Yoshida, Masashi Aonuma
  • Publication number: 20120264738
    Abstract: A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.
    Type: Application
    Filed: March 9, 2012
    Publication date: October 18, 2012
    Inventors: Yuuichi Sugimoto, Kouichi Uoto, Takanori Wakabayashi, Masaki Miyazaki, Masaki Setoguchi, Toru Taniguchi, Keisuke Yoshida, Akitake Yamaguchi, Shoko Yoshida
  • Patent number: 8290869
    Abstract: Automated teller machine systems and methods for reducing system development efforts by financial institutions and for providing a financial transaction system that is adapted for using one or more common ATMs. In addition, systems and methods to simplify settlement processing of transactions based on ATMs of each financial institution. ATMs and center systems of financial institutions are dissociated from each other, and a relay center intervenes between them.
    Type: Grant
    Filed: May 22, 2008
    Date of Patent: October 16, 2012
    Assignee: International Business Machines Corporation
    Inventors: Masaki Miyazaki, Akira Hasegawa
  • Publication number: 20110301176
    Abstract: There is provided compounds that inhibit interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. Compounds include imidazothiazole derivatives that can inhibit interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity.
    Type: Application
    Filed: July 15, 2011
    Publication date: December 8, 2011
    Inventors: Kouichi Uoto, Yuuichi Sugimoto, Hiroyuki Naito, Masaki Miyazaki, Keisuke Yoshida, Masashi Aonuma
  • Patent number: 7744787
    Abstract: In monitoring anomalies in a measurement process comprising a main measurement process Sa which performs a measurement by forward rotating a screw 3 having a back-flow prevention valve 2 installed on the tip and a post-measurement process which performs a post-measurement process Sb for closing said back-flow prevention valve 2 after this main measurement process Sa ends, after said post-measurement process Sb ends, an injection process Si wherein said screw 3 is put in a freely-rotatable state and moved forward is performed, the amount of rotation Rd of said screw 3 since the start of this injection process Si is detected, and if the detected amount of rotation Rd exceeds at least a preset amount Rs, an anomaly processing (S9) is performed.
    Type: Grant
    Filed: September 5, 2007
    Date of Patent: June 29, 2010
    Assignee: Nissei Plastic Industrial Co., Ltd.
    Inventors: Toshimi Kato, Takashi Hakoda, Masaki Miyazaki
  • Patent number: 7678303
    Abstract: A measurement method including a main measurement process Sa in which measurement is performed by rotating a screw in the forward direction with a back-flow prevention valve installed on its tip and a post-measurement process Sb which is performed by rotating the screw in a reverse direction after the main measurement process Sa is finished, the post-measurement process Sb being performed after completing the main measurement process Sa, in which the screw is moved forward in a free rotational state, the rotational state of the screw during the forward movement being monitored, and if the rotation of screw comes to a halt, the screw is rotated in a reverse direction by a specified amount of rotation.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: March 16, 2010
    Assignee: Nissei Plastic Industrial Co., Ltd.
    Inventors: Haruo Okada, Toshimi Kato, Masaki Miyazaki, Hiroo Kudo
  • Publication number: 20090312310
    Abstract: There is provided a novel compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. The present invention provides an imidazothiazole derivative represented by the following formula (1) having various substituents that inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity: wherein R1, R2, R3, R4, and R5 in the formula (1) each has the same meaning as defined in the specification.
    Type: Application
    Filed: June 11, 2009
    Publication date: December 17, 2009
    Inventors: Haruko Kawato, Masaki Miyazaki, Yuuichi Sugimoto, Hiroyuki Naito, Tooru Okayama, Tsunehiko Soga, Kouichi Uoto
  • Publication number: 20080272190
    Abstract: Automated teller machine systems and methods for reducing system development efforts by financial institutions and for providing a financial transaction system that is adapted for using one or more common ATMs. In addition, systems and methods to simplify settlement processing of transactions based on ATMs of each financial institution. ATMs and center systems of financial institutions are dissociated from each other, and a relay center intervenes between them.
    Type: Application
    Filed: May 22, 2008
    Publication date: November 6, 2008
    Inventors: Masaki Miyazaki, Akira Hasegawa
  • Patent number: 7401051
    Abstract: Automated teller machine systems and methods for reducing system development efforts by financial institutions and for providing a financial transaction system that is adapted for using one or more common ATMs. In addition, systems and methods to simplify settlement processing of transactions based on ATMs of each financial institution. ATMs and center systems of financial institutions are dissociated from each other, and a relay center intervenes between them.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: July 15, 2008
    Assignee: International Business Machines Corporation
    Inventors: Masaki Miyazaki, Akira Hasegawa
  • Publication number: 20080065356
    Abstract: In monitoring anomalies in a measurement process comprising a main measurement process Sa which performs a measurement by forward rotating a screw 3 having a back-flow prevention valve 2 installed on the tip and a post-measurement process which performs a post-measurement process Sb for closing said back-flow prevention valve 2 after this main measurement process Sa ends, after said post-measurement process Sb ends, an injection process Si wherein said screw 3 is put in a freely-rotatable state and moved forward is performed, the amount of rotation Rd of said screw 3 since the start of this injection process Si is detected, and if the detected amount of rotation Rd exceeds at least a preset amount Rs, an anomaly processing (S9) is performed.
    Type: Application
    Filed: September 5, 2007
    Publication date: March 13, 2008
    Inventors: Toshimi Kato, Takashi Hakoda, Masaki Miyazaki
  • Patent number: 7189278
    Abstract: A method for producing semiconductor or metal particles comprises the steps of: storing a semiconductor or metal melt in a crucible having a nozzle; supplying a gas comprising at least one selected from the group consisting of He, Ne, Ar, Kr and Xe into the crucible such that the pressure of the supplied gas in a space over the melt in the crucible is higher than the pressure of a gaseous phase into which the melt is dropped; dropping the melt from the nozzle into the gaseous phase by the pressure of the gas to form liquid particles; and solidifying the liquid particles in the gaseous phase to obtain semiconductor or metal particles. The crucible comprises at least one selected from the group consisting of hexagonal BN, cubic BN, Si3N4, TiB2, ZrB2, zirconia and stabilized zirconia at least near the nozzle.
    Type: Grant
    Filed: April 18, 2003
    Date of Patent: March 13, 2007
    Assignee: Clean Venture 21 Corporation
    Inventors: Kenji Kato, Yukio Yamaguchi, Seiichi Isomae, Masaki Miyazaki
  • Publication number: 20040007790
    Abstract: A method for producing semiconductor or metal particles comprises the steps of: storing a semiconductor or metal melt in a crucible having a nozzle; supplying a gas comprising at least one selected from the group consisting of He, Ne, Ar, Kr and Xe into the crucible such that the pressure of the supplied gas in a space over the melt in the crucible is higher than the pressure of a gaseous phase into which the melt is dropped; dropping the melt from the nozzle into the gaseous phase by the pressure of the gas to form liquid particles; and solidifying the liquid particles in the gaseous phase to obtain semiconductor or metal particles. The crucible comprises at least one selected from the group consisting of hexagonal BN, cubic BN, Si3N4, TiB2, ZrB2, zirconia and stabilized zirconia at least near the nozzle.
    Type: Application
    Filed: April 18, 2003
    Publication date: January 15, 2004
    Inventors: Kenji Kato, Yukio Yamaguchi, Seiichi Isomae, Masaki Miyazaki
  • Patent number: D767398
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: September 27, 2016
    Assignee: HISAMITSU PHARMACEUTICAL CO., LTD.
    Inventors: Masaki Miyazaki, Shigeo Kusumi
  • Patent number: D774400
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: December 20, 2016
    Assignee: HISAMITSU PHARMACEUTICAL CO., INC.
    Inventors: Masaki Miyazaki, Shigeo Kusumi